bioterapevt.elpub.ru

About the project

Russian Biotherapeutic Journalis a scientific publication that has been operating for more than two decades. It has been published since 2002 and specializes in complex issues in the treatment of immunological and oncological diseases. bioterapijas platforma. elpub. ru acts not just as an archive, but as an active resource for the exchange of data between doctors and researchers.

The magazine positions itself as a theoretical, scientific and practical source. Here we publish materials that relate not only to theory, but also to real problems of diagnosis and therapy. Particular attention is paid to new biomarkers and their role in the treatment of malignant neoplasms.

Main directions

The content of the site is strictly focused on highly specialized areas of medicine and science. The main topics of publications include:

• Study of new biomarkers in oncology and pathologies of the immune system.
• Use of these markers in diagnosis and selection of therapy.
• Drug therapy and issues of creating new drugs.
• Technologies for conducting preclinical and clinical studies.

An example of relevance is the literature review from the current issue (Vol. 24, 2, 2025). It examines the molecular genetic features of the immune mechanisms of osteoarthritis. The authors analyze the role of specific genes and microRNAs that influence inflammatory processes. This shows that the journal keeps up with the latest data in the field of targeted therapy.

Features of the site

The site is integrated with a large scientific infrastructure. It is hosted on the platform of the Scientific Electronic Library and is registered with the RSCI. This means that full-text versions of articles are available starting from 2002. This is important for researchers: all issues are archived and indexed.

Arī citēšanas rādītāji ir skaidri redzami. According to the RSCI analysis, the five-year impact factor of the journal is 0.603. The editorial board consists of leading Russian scientists, which guarantees a high level of peer review.

The audience of the resource is clearly defined - these are oncologists, immunologists, as well as employees of laboratories of molecular biology, biochemistry and pharmacology. The site provides advanced search tools and allows you to download issues in PDF format.

Contact information

There are no direct contact information (address, telephone or email of the editorial office) in the texts provided on the site. There are only standard interface elements: a login form for users, links to rules for authors, and sections with information about publishing ethics and peer review.

Bieži uzdotie jautājumi

            domain:        ELPUB.RU
nserver:       ns4-cloud.nic.ru.
nserver:       ns4-l2.nic.ru.
nserver:       ns8-cloud.nic.ru.
nserver:       ns8-l2.nic.ru.
nserver:       ns.elpub-dns.ru.
state:         REGISTERED, DELEGATED, VERIFIED
person:        Private Person
registrar:     RU-CENTER-RU
admin-contact: https://www.nic.ru/whois
created:       2012-01-27T09:34:05Z
paid-till:     2027-01-27T10:34:05Z
free-date:     2027-02-27
source:        TCI
Last updated on 2026-06-09T13:28:01Z
        

Tehniskais SEO

SEO lapā

Saturs un UX